BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7534418)

  • 21. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
    Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
    Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
    Blackbourn DJ; Mackewicz CE; Barker E; Hunt TK; Herndier B; Haase AT; Levy JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13125-30. PubMed ID: 8917555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of CD8+ T lymphocyte-mediated nonlytic suppression of autologous and heterologous primary human immunodeficiency virus type 1 isolates.
    Kootstra NA; Miedema F; Schuitemaker H
    AIDS Res Hum Retroviruses; 1997 May; 13(8):685-93. PubMed ID: 9168237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nuclear factor kappa B and Spl binding sites do not appear to be involved in virus suppression by CD8 T lymphocytes.
    Locher CP; Witt SA; Levy JA
    AIDS; 2001 Dec; 15(18):2455-7. PubMed ID: 11774833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cytotoxicity and cytokine release of CD8+ HIV-specific cytotoxic T lymphocytes by pentoxifylline.
    Heinkelein M; Schneider-Schaulies J; Walker BD; Jassoy C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):417-24. PubMed ID: 7583437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+ T cell-mediated enhancement of tumour necrosis factor-alpha (TNF-alpha) production and HIV-1 LTR-driven gene expression in human monocytic cells is pertussis toxin-sensitive.
    Copeland KF; McKay PJ; Newton J; Rosenthal KL
    Clin Exp Immunol; 1999 Jun; 116(3):479-85. PubMed ID: 10361238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8
    Mota TM; McCann CD; Danesh A; Huang SH; Magat DB; Ren Y; Leyre L; Bui TD; Rohwetter TM; Kovacs CM; Benko E; MacLaren L; Wimpelberg A; Cannon CM; Hardy WD; Safrit JT; Jones RB
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32051267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells.
    Blazek D; Teque F; Mackewicz C; Peterlin M; Levy JA
    J Gen Virol; 2016 Jan; 97(1):220-224. PubMed ID: 26499373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture.
    Wiviott LD; Walker CM; Levy JA
    Cell Immunol; 1990 Jul; 128(2):628-34. PubMed ID: 1972661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ T-cell-mediated non-cytolytic suppression of human immuno-deficiency viruses.
    Vella C; Daniels RS
    Curr Drug Targets Infect Disord; 2003 Jun; 3(2):97-113. PubMed ID: 12769788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease.
    Gómez AM; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1994 Jul; 97(1):68-75. PubMed ID: 7518369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8+ T cell-mediated suppression of human immunodeficiency virus replication in older children with acquired immunodeficiency syndrome.
    Salimi B; Yogev R; Kabat W; O'Gorman MR; Katz BZ
    Pediatr Infect Dis J; 2000 Feb; 19(2):109-13. PubMed ID: 10693995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8
    Policicchio BB; Cardozo EF; Sette P; Xu C; Haret-Richter G; Dunsmore T; Apetrei C; Pandrea I; Ribeiro RM
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G; Montaner LJ; Gordon S
    J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
    Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
    J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T cell-mediated suppression of HIV long terminal repeat-driven gene expression is not associated with improved clinical status.
    Copeland KF; Leith JG; McKay PJ; Kelleher L; Smaill FM; Rosenthal KL
    AIDS; 1997 Apr; 11(5):581-6. PubMed ID: 9108939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of the antiviral activity of CD8(+) T cells from human immunodeficiency virus-positive asymptomatic patients with different rates of CD4(+) T-cell decrease.
    Salerno-Gonçalves R; Lu W; Andrieu JM
    J Virol; 2000 Jul; 74(14):6648-51. PubMed ID: 10864680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.